Geopulse Exploration (dba Cannco Brands and Development) Delivers Corporate Update Corporate, Financial, Commercial, and Development Matters Discussed LOS ANGELES, CA, Nov. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Geopulse Exploration (dba Cannco Brands and Development)...

Rich Pharmaceuticals Reaches Agreement with Geopulse Exploration, Inc. (Cannco Brands) LOS ANGELES, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) has agreed to be partially acquired by Geopulse Exploration, Inc. (OTC PINK: GPLS),...

Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...

UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...

Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...